Newsroom | 5160 results

Sorted by: Latest

Radiology
-

Cleerly to Debut Cleerly PREVIEW and Showcase New AI-QCT Research at ACC.26

DENVER--(BUSINESS WIRE)--Cleerly, a leader in advanced cardiovascular imaging analysis, will be attending the 75th Annual Scientific Session & Expo of the American College of Cardiology (ACC.26). The conference will take place March 28–30, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. ACC.26 convenes clinicians, researchers, and innovators from around the world to advance the science and practice of heart care. Cleerly will mark the conference with the launch of...
-

Kallisio Receives CE Mark for Stentra™ Precision Oral Immobilization System

BALTIMORE--(BUSINESS WIRE)--Kallisio has received CE certification for its Stentra™ oral immobilization system designed for precise, repeatable head and neck radiation therapy....
-

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies will host a webinar on April 8 with leading pulmonologists who will share their clinical experience with CyPath Lung....
-

Virchow Raises $4 Million to Advance Biopsy Specimen Stewardship and Expand Access to Precision Oncology

LA JOLLA, Calif.--(BUSINESS WIRE)--Virchow Medical raises $4M seed financing led by Cerberus Ventures to advance biopsy specimen stewardship and expand access to precision oncology....
-

Mirion Crew Active Dosimeters to Be Worn by Astronauts on NASA's Artemis II Mission

ATLANTA--(BUSINESS WIRE)--As NASA prepares for the Artemis II launch, Mirion, a leading provider of advanced radiation safety solutions, today announced that its Crew Active Dosimeters (CAD) will be carried in astronauts’ pockets aboard the Artemis II mission, providing personal, time-resolved radiation monitoring during the program’s first crewed flight. Artemis II will carry astronauts on an approximately 10-day mission around the Moon, marking a major milestone in NASA’s Artemis program to r...
-

QT Imaging Receives UAE Regulatory Clearance

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the United Arab Emirates (UAE) Emirates Drug Establishment (EDE) for use as a medical device in that country. This clearance allows for the importation a...
-

Premier Anesthesia Expands Partnership with Washington Regional Medical Center in Northwest Arkansas

ALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, a leading, privately held anesthesia practice management firm, today announced the expansion of its partnership with Washington Regional Medical Center to provide anesthesia services at two additional facilities in Northwest Arkansas: Washington Regional’s North Hills Surgery Center and Physicians’ Specialty Hospital. These strategic additions reflect Premier Anesthesia’s ongoing commitment in Arkansas and further strengthen its collaboratio...
-

GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra,i an innovative photon‑counting computed tomography (PCCT) solution powered by the company’s novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. With wide coverage and the combination of ultra-high definition (UHD) spatial and spectral imaging, Photonova Spec...
-

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) (“Hyperfine”), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth. Hyperfine is a publicly traded health technology company that has developed and is commercializing the Swoop® System, t...
-

Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue

ORLANDO, Fla.--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers. As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential...